CLEARVISE AG (ABO.DE) Fundamental Analysis & Valuation

FRA:ABO • DE000A1EWXA4

1.46 EUR
+0.03 (+2.1%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This ABO.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall ABO gets a fundamental rating of 3 out of 10. We evaluated ABO against 20 industry peers in the Independent Power and Renewable Electricity Producers industry. ABO has a bad profitability rating. Also its financial health evaluation is rather negative. ABO has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. ABO.DE Profitability Analysis

1.1 Basic Checks

  • ABO had negative earnings in the past year.
  • ABO had a positive operating cash flow in the past year.
  • ABO had positive earnings in 4 of the past 5 years.
  • ABO had a positive operating cash flow in each of the past 5 years.
ABO.DE Yearly Net Income VS EBIT VS OCF VS FCFABO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • ABO has a worse Return On Assets (-0.17%) than 60.00% of its industry peers.
  • Looking at the Return On Equity, with a value of -0.44%, ABO is doing worse than 60.00% of the companies in the same industry.
  • The Return On Invested Capital of ABO (0.99%) is worse than 65.00% of its industry peers.
  • ABO had an Average Return On Invested Capital over the past 3 years of 2.94%. This is in line with the industry average of 4.81%.
Industry RankSector Rank
ROA -0.17%
ROE -0.44%
ROIC 0.99%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.94%
ROIC(5y)2.51%
ABO.DE Yearly ROA, ROE, ROICABO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • ABO has a Operating Margin of 18.24%. This is in the better half of the industry: ABO outperforms 75.00% of its industry peers.
  • In the last couple of years the Operating Margin of ABO has declined.
  • Looking at the Gross Margin, with a value of 96.58%, ABO belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ABO has remained more or less at the same level.
Industry RankSector Rank
OM 18.24%
PM (TTM) N/A
GM 96.58%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
ABO.DE Yearly Profit, Operating, Gross MarginsABO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ABO.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ABO is destroying value.
  • The number of shares outstanding for ABO remains at a similar level compared to 1 year ago.
  • ABO has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ABO is higher compared to a year ago.
ABO.DE Yearly Shares OutstandingABO.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ABO.DE Yearly Total Debt VS Total AssetsABO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • Based on the Altman-Z score of 0.57, we must say that ABO is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.57, ABO is doing worse than 65.00% of the companies in the same industry.
  • The Debt to FCF ratio of ABO is 21.45, which is on the high side as it means it would take ABO, 21.45 years of fcf income to pay off all of its debts.
  • ABO's Debt to FCF ratio of 21.45 is fine compared to the rest of the industry. ABO outperforms 70.00% of its industry peers.
  • ABO has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
  • ABO has a worse Debt to Equity ratio (1.35) than 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 21.45
Altman-Z 0.57
ROIC/WACC0.27
WACC3.61%
ABO.DE Yearly LT Debt VS Equity VS FCFABO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.62 indicates that ABO should not have too much problems paying its short term obligations.
  • ABO's Current ratio of 1.62 is on the low side compared to the rest of the industry. ABO is outperformed by 60.00% of its industry peers.
  • A Quick Ratio of 1.62 indicates that ABO should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.62, ABO is in line with its industry, outperforming 45.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.62
ABO.DE Yearly Current Assets VS Current LiabilitesABO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ABO.DE Growth Analysis

3.1 Past

  • The earnings per share for ABO have decreased strongly by -88.89% in the last year.
  • ABO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.53%.
  • ABO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.75% yearly.
EPS 1Y (TTM)-88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%3.62%

3.2 Future

  • The Earnings Per Share is expected to grow by 64.65% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 7.97% on average over the next years.
EPS Next Y87.82%
EPS Next 2Y115%
EPS Next 3Y64.65%
EPS Next 5YN/A
Revenue Next Year10.19%
Revenue Next 2Y13.51%
Revenue Next 3Y7.97%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABO.DE Yearly Revenue VS EstimatesABO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ABO.DE Yearly EPS VS EstimatesABO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 0.15

More info and screens

Find the best growth stocksShow best growing peers

4

4. ABO.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Forward Earnings ratio is 20.17, which indicates a rather expensive current valuation of ABO.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ABO.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.57, ABO is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 20.17
ABO.DE Price Earnings VS Forward Price EarningsABO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ABO is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABO indicates a rather cheap valuation: ABO is cheaper than 90.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10
EV/EBITDA 14.07
ABO.DE Per share dataABO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

  • ABO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ABO's earnings are expected to grow with 64.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y115%
EPS Next 3Y64.65%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. ABO.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.20%, ABO is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.32, ABO pays a better dividend. On top of this ABO pays more dividend than 85.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ABO pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.2%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ABO.DE Yearly Dividends per shareABO.DE Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

DP0%
EPS Next 2Y115%
EPS Next 3Y64.65%
ABO.DE Yearly Income VS Free CF VS DividendABO.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

More info and screens

Find the best dividend stocksShow peers with best dividend

ABO.DE Fundamentals: All Metrics, Ratios and Statistics

CLEARVISE AG

FRA:ABO (3/6/2026, 7:00:00 PM)

1.46

+0.03 (+2.1%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)11-14
Earnings (Next)04-15
Inst Owners4.79%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap110.03M
Revenue(TTM)35.41M
Net Income(TTM)-710.00K
Analysts85.71
Price Target2.82 (93.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.2%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-113.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.07%
Revenue NY rev (3m)-4.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.17
P/S 3.11
P/FCF 10
P/OCF 10
P/B 0.68
P/tB 0.68
EV/EBITDA 14.07
EPS(TTM)0
EYN/A
EPS(NY)0.07
Fwd EY4.96%
FCF(TTM)0.15
FCFY10%
OCF(TTM)0.15
OCFY10%
SpS0.47
BVpS2.14
TBVpS2.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.17%
ROE -0.44%
ROCE 1.64%
ROIC 0.99%
ROICexc 1.05%
ROICexgc 1.05%
OM 18.24%
PM (TTM) N/A
GM 96.58%
FCFM 31.06%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.94%
ROIC(5y)2.51%
ROICexc(3y)3.51%
ROICexc(5y)2.93%
ROICexgc(3y)3.54%
ROICexgc(5y)2.98%
ROCE(3y)4.87%
ROCE(5y)4.15%
ROICexgc growth 3Y9.43%
ROICexgc growth 5Y-12.73%
ROICexc growth 3Y10.43%
ROICexc growth 5Y-12.09%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 21.45
Debt/EBITDA 9.52
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 48.28%
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.62
Altman-Z 0.57
F-Score4
WACC3.61%
ROIC/WACC0.27
Cap/Depr(3y)122.48%
Cap/Depr(5y)90.46%
Cap/Sales(3y)45.96%
Cap/Sales(5y)37.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y87.82%
EPS Next 2Y115%
EPS Next 3Y64.65%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%3.62%
Revenue Next Year10.19%
Revenue Next 2Y13.51%
Revenue Next 3Y7.97%
Revenue Next 5YN/A
EBIT growth 1Y-59.38%
EBIT growth 3Y29.64%
EBIT growth 5Y-1.33%
EBIT Next Year435.45%
EBIT Next 3Y84.85%
EBIT Next 5YN/A
FCF growth 1Y-69.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.96%
OCF growth 3Y-6.75%
OCF growth 5Y-8.15%

CLEARVISE AG / ABO.DE FAQ

Can you provide the ChartMill fundamental rating for CLEARVISE AG?

ChartMill assigns a fundamental rating of 3 / 10 to ABO.DE.


Can you provide the valuation status for CLEARVISE AG?

ChartMill assigns a valuation rating of 5 / 10 to CLEARVISE AG (ABO.DE). This can be considered as Fairly Valued.


What is the profitability of ABO stock?

CLEARVISE AG (ABO.DE) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for ABO stock?

The Earnings per Share (EPS) of CLEARVISE AG (ABO.DE) is expected to grow by 87.82% in the next year.


How sustainable is the dividend of CLEARVISE AG (ABO.DE) stock?

The dividend rating of CLEARVISE AG (ABO.DE) is 6 / 10 and the dividend payout ratio is 0%.